CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response

Clinical and Experimental Immunology

Volumn 176, Issue 2, 2014, Pages 238-245

  Wang, H ^a   Zhao, J ^a   Zhang, H ^a   Huang, Y ^a   Wang, S ^a   Tu, Q ^b   Yang, N ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

CARD11; Collagen induced arthritis; Small interfering RNA; Th17 cells

Indexed keywords

CASPASE RECRUITMENT DOMAIN CONTAINING PROTEIN 11; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE EROSION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; FLOW CYTOMETRY; HISTOLOGY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; JOINT DESTRUCTION; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MURINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; SYNOVITIS; TH17 CELL;

CARD11; COLLAGEN-INDUCED ARTHRITIS; SMALL INTERFERING RNA; TH17 CELLS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; BLOTTING, WESTERN; CARD SIGNALING ADAPTOR PROTEINS; COLLAGEN TYPE II; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED DBA; NF-KAPPA B; PROTEIN BINDING; RNA INTERFERENCE; SYNOVIAL MEMBRANE; TH17 CELLS; X-RAY MICROTOMOGRAPHY;

EID: 84897943791     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12275     Document Type: Article

References (40)

1. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001; 44:2009-2017.
2. Kwok SK, Cho ML, Park MK etal. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum 2012; 64:740-751.
3. Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxf) 2012; 51 (Suppl. 6):vi28-36.
4. Yazici Y. Treatment of rheumatoid arthritis: we are getting there. Lancet 2009; 374:178-180.
5. Bertin J, Wang L, Guo Y etal. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 2001; 276:11877-11882.
6. Liu Y, Song R, Gao Y etal. Protein kinase C-delta negatively regulates T cell receptor-induced NF-kappaB activation by inhibiting the assembly of CARMA1 signalosome. J Biol Chem 2012; 287:20081-20087.
7. Blonska M, Lin X. CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev 2009; 228:199-211.
8. van Loo G, Beyaert R. Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis. Arthritis Res Ther 2011; 13:221.
9. Simelyte E, Rosengren S, Boyle DL, Corr M, Green DR, Firestein GS. Regulation of arthritis by p53: critical role of adaptive immunity. Arthritis Rheum 2005; 52:1876-1884.
10. Zhao J, Wang H, Dai C etal. P2X7 blockade attenuates lupus nephritis by inhibiting NLRP3/ASC/caspase-1 activation. Arthritis Rheum 2013; 65:3176-3185.
11. Mezzaroma E, Toldo S, Farkas D etal. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 2011; 108:19725-19730.
12. Camps M, Ruckle T, Ji H etal. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11:936-943.
13. Suchard SJ, Stetsko DK, Davis PM etal. An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis. J Immunol 2010; 184:3917-3926.
14. Palkowitsch L, Marienfeld U, Brunner C, Eitelhuber A, Krappmann D, Marienfeld RB. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation. J Biol Chem 2011; 286:7522-7534.
15. Musacchio T, Torchilin VP. siRNA delivery: from basics to therapeutic applications. Front Biosci (Landmark Ed) 2013; 18:58-79.
16. Courties G, Baron M, Presumey J etal. Cytosolic phospholipase A2alpha gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis. Arthritis Rheum 2011; 63:681-690.
17. Medoff BD, Seed B, Jackobek R etal. CARMA1 is critical for the development of allergic airway inflammation in a murine model of asthma. J Immunol 2006; 176:7272-7277.
18. Ramadas RA, Roche MI, Moon JJ, Ludwig T, Xavier RJ, Medoff BD. CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma. J Immunol 2011; 187:6197-6207.
19. Blonska M, Joo D, Zweidler-McKay PA, Zhao Q, Lin X. CARMA1 controls Th2 cell-specific cytokine expression through regulating JunB and GATA3 transcription factors. J Immunol 2012; 188:3160-3168.
20. Molinero LL, Cubre A, Mora-Solano C, Wang Y, Alegre MLT. cell receptor/CARMA1/NF-kappaB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci USA 2012; 109:18529-18534.
21. Karmakar S, Kay J, Gravallese EM. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am 2010; 36:385-404.
22. Roman-Blas JA, Jimenez SA. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis. Int Rev Immunol 2008; 27:351-374.
23. Min SY, Yan M, Du Y etal. Intra-articular nuclear factor-kappaB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages. Clin Exp Immunol 2013; 172:217-227.
24. Okamoto H, Yoshio T, Kaneko H, Yamanaka H. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. Arthritis Rheum 2010; 62:82-92.
25. Criswell LA. Gene discovery in rheumatoid arthritis highlights the CD40/NF-kappaB signaling pathway in disease pathogenesis. Immunol Rev 2010; 233:55-61.
26. Ghivizzani SC, Kang R, Georgescu HI etal. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 1997; 159:3604-3612.
27. Horai R, Saijo S, Tanioka H etal. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191:313-320.
28. Ohshima S, Saeki Y, Mima T etal. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 1998; 95:8222-8226.
29. Ash Z, Emery P. The role of tocilizumab in the management of rheumatoid arthritis. Expert Opin Biol Ther 2012; 12:1277-1289.
30. Kim KW, Cho ML, Park MK etal. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7:R139-148.
31. Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998; 161:409-414.
32. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11:763-776.
33. Mullazehi M, Wick MC, Klareskog L, van Vollenhoven R, Ronnelid J. Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis. Arthritis Res Ther 2012; 14:R100.
34. Jeelall YS, Wang JQ, Law HD etal. Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production. J Exp Med 2012; 209:1907-1917.
35. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181:8-18.
36. Stepensky P, Keller B, Buchta M etal. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J Allergy Clin Immunol 2013; 131:477-485.
37. Greil J, Rausch T, Giese T etal. Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. J Allergy Clin Immunol 2013; 131:1376-1833.
38. Rajasekaran K, Kumar P, Schuldt KM etal. Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nat Immunol 2013; 14:1127-1136.
39. Roche MI, Ramadas RA, Medoff BD. The role of CARMA1 in T cells. Crit Rev Immunol 2013; 33:219-243.
40. van Vollenhoven RF, Fleischmann R, Cohen S etal. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N Engl J Med 2012; 367:508-519.